<DOC>
	<DOC>NCT00967811</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and preliminary efficacy of two formulations of the Latanoprost-PPDS in subjects with ocular hypertension or open-angle glaucoma.</brief_summary>
	<brief_title>A Study of Different Formulations of the L-PPDS in Subjects With OH or OAG</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<criteria>Subjects over 18 years of age diagnosed with ocular hypertension or openangle glaucoma Subjects who have a best corrected visual acuity of 20/100 or better Subjects who wear contact lenses Subjects who have uncontrolled medical conditions Subjects requiring chronic topical artificial tears, lubricants, and/or requiring any other chronic ocular topical medications Subjects who have a history of chronic or recurrent inflammatory eye disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>